Eric N. Olson, PhD, of the the University of Texas Southwestern Medical Center, co-founder and chief science advisor of Exonics Therapeutics. The company is being acquired by Vertex Pharmaceuticals ...
Bears Vertex is highly dependent on the success of its cystic fibrosis franchise, and it could fail to diversify if its other pipeline candidates are not successful. Pricing pressure could erode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback